Radiculopathy

disease
On this page

Also known as nerve root disorder

Summary

Radiculopathy (MONDO:0002959) is a disease and 81 clinical trials. Top therapeutic interventions include sumatriptan, tizanidine, and baclofen. A subtype of peripheral nervous system disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 81

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameradiculopathy
Mondo IDMONDO:0002959
MeSHD011843
DOIDDOID:4306
ICD-10-CMM54.1
ICD-111802542189
SNOMED CT72274001
UMLSC0700594
MedGen147133
Is cancer (heuristic)no

Also known as: nerve root disorder

Disease family

This is a subtype of peripheral nervous system disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorderperipheral nervous system disorderradiculopathy

Related subtypes (17): autoimmune disorder of peripheral nervous system, autonomic nervous system disorder, peripheral nervous system neoplasm, vestibulocochlear nerve disorder, hypoglossal nerve disorder, facial nerve disorder, neuroma, accessory nerve disorder, glossopharyngeal nerve disorder, olfactory nerve disorder, trigeminal nerve disorder, third cranial nerve disorder, peripheral neuropathy, cauda equina syndrome, peroneal nerve paralysis, trochlear nerve disorder, abducens nerve disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated for this disease

0 approved, 4 in late-stage (phase 3) trials. Disease-direct ChEMBL indications, not inferred from the associated-gene cohort below.

DrugDevelopment status
BupivacainePhase 3 (in late-stage trials)
PregabalinPhase 3 (in late-stage trials)
TriamcinolonePhase 3 (in late-stage trials)
Triamcinolone AcetonidePhase 3 (in late-stage trials)

Earlier-phase candidates (phase 2, investigational — efficacy not yet established): Dexamethasone, Etanercept, Lenalidomide, Methylprednisolone, Sodium Chloride, Vixotrigine.

Clinical trials & evidence

Clinical trials

Clinical trials: 81.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified61
PHASE38
PHASE24
PHASE2/PHASE33
PHASE12
PHASE41
PHASE1/PHASE21
EARLY_PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT02265848PHASE4COMPLETEDHigh Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System
NCT00120120PHASE2/PHASE3COMPLETEDStudy to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy
NCT00159705PHASE3COMPLETEDTrial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
NCT00578812PHASE3COMPLETEDPCM Cervical Disc System
NCT00942227PHASE3COMPLETEDThe Value of Traction in Treatment of Lumbar Radiculopathy
NCT00979108PHASE3COMPLETEDThe Value of Traction in the Treatment of Cervical Radiculopathy
NCT01073995PHASE3COMPLETEDThe Effectiveness of Selective Nerve Root Injections in Preventing the Need for Surgery
NCT01905930PHASE3COMPLETEDPost-Approval Clinical Trial of the PCM® Cervical Disc
NCT02618278PHASE3COMPLETEDPhysiotherapy for Sciatica; Is Earlier Better?
NCT03327272PHASE3WITHDRAWNImpact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion
NCT04559295PHASE2/PHASE3UNKNOWNBone Marrow Concentrate (BMC) Injection in Intervertebral Discs
NCT04621799PHASE2/PHASE3UNKNOWNFibrin for Chronic Multi-level Discogenic Low Back Pain
NCT00009672PHASE2COMPLETEDPain Treatment for Sciatica
NCT00107055PHASE2UNKNOWNStudy of REN-1654 in Patients With Sciatica Pain
NCT01088256PHASE2TERMINATEDEfficacy of Etoricoxib on Peripheral Hyperalgesia
NCT01873404PHASE2COMPLETEDBG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
NCT04760613PHASE1/PHASE2COMPLETEDCBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)
NCT02644421PHASE1COMPLETEDClinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)
NCT03556137PHASE1UNKNOWNPET/MRI in the Diagnosis of Chronic Pain
NCT05261581EARLY_PHASE1WITHDRAWNEvaluation of Erector Spina Plane Block(ESPB)’s Effectiveness on Patients With Lumbar Radiculopathy
NCT04273828Not specifiedRECRUITINGImpact of Muscle Degeneration in Chronic Low Back Pain
NCT04909138Not specifiedRECRUITINGIntermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
NCT05035693Not specifiedRECRUITINGPost Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
NCT05696470Not specifiedACTIVE_NOT_RECRUITINGFusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs
NCT05745129Not specifiedENROLLING_BY_INVITATIONApplying Artificial Intelligence in Developing Personalized and Sustainable Healthcare for Spinal Disorders
NCT05817747Not specifiedRECRUITINGStrategic Use of Big Data in Spine Surgery - Testing Digital Prediction of Outcome in Clinical Praxis
NCT05952167Not specifiedRECRUITINGEvaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical Radiculopathy
NCT06891690Not specifiedRECRUITINGUse of TDCS Stimulation in Neurological and Gynaecological Conditions
NCT06956664Not specifiedRECRUITINGExercise Therapy After Caudal Epidural Steroid Injection
NCT07080307Not specifiedNOT_YET_RECRUITINGArtificial Intelligence (AI)-Based Prediction of Treatment Response in Sciatica Patients Receiving Transforaminal Epidural Steroid Injection
NCT07366983Not specifiedNOT_YET_RECRUITINGEffect of Cervical Traction With Neural Mobilization on Nerve Root Functions in Cervical Radiculopathy Patients
NCT07543692Not specifiedNOT_YET_RECRUITINGSafety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases
NCT07558993Not specifiedNOT_YET_RECRUITINGMirror Image Spine Correction Exercises Versus Conservative Physiotherapy for Lumbar Radiculopathy
NCT00437190Not specifiedCOMPLETEDPivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDF
NCT00440856Not specifiedCOMPLETEDPresentation of Lumbar Disc and Reduction of Symptoms
NCT00546949Not specifiedTERMINATEDTreatment of Lumbar Spinal Stenosis; Comparison of Two Different Surgical Methods; Mini-invasive Decompression to X-stop
NCT00585923Not specifiedTERMINATEDSlotted Hole Versus Fixed Hole C-Tek
NCT00637156Not specifiedCOMPLETEDStudy of the Safety and Effectiveness of the Artificial Cervical Disc - Low Profile Device at Two Adjacent Levels
NCT00894972Not specifiedCOMPLETEDRehabilitation Following Lumbar Disc Surgery
NCT00934284Not specifiedCOMPLETEDEffectiveness Study of Physical Therapy as an Adjunct to a Lumbar Therapeutic Selective Nerve Root Block

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
SUMATRIPTAN43
TIZANIDINE42
BACLOFEN41
BUPIVACAINE41
CYCLOBENZAPRINE41
ESFLURBIPROFEN41
ETORICOXIB41
FLURBIPROFEN41
LENALIDOMIDE41
MELOXICAM41
MENTHOL41
NORTRIPTYLINE41
PRILOCAINE41
TRIAMCINOLONE ACETONIDE41
FIBRIN31
LEVOMENTHOL31
ZUCAPSAICIN31
ARTEMIN21